Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleena Koep

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Health Affairs Scholar|January 15, 2026
Decomposition of trauma care prices between 2019 and 2022 in the US commercially insured populationElena Andreyeva, Eleena Koep, Protima Advani, et al.
Current Medical Research and Opinion|August 10, 2018
Cost of subcutaneous immunotherapy in a large insured population in the United StatesJianbin Mao, Kim A Heithoff, Eleena Koep, et al.
Current Medical Research and Opinion|June 18, 2021
Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illnessFelicia Forma, Eleena Koep, John White, et al.
Pragmatic and Observational Research|June 24, 2021
Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart AbstractionCarolyn Martin, Eleena Koep, John White, et al.
Pulmonary Circulation|November 14, 2018
Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US databaseSean Studer, Michael Hull, Janis Pruett, et al.
Health Services Research|August 2, 2023
Role of prices in driving the variation in spending across medical groupsAteev Mehrotra, Emily D Parker, Eleena Koep, et al.
The American Journal of Managed Care|July 27, 2021
Variation in spending associated with primary care practicesSamuel Moy, Eleena Koep, Emily D Parker, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 20, 2019
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort studyChad Moretz, Lucie Sharpsten, Lindsay Gs Bengtson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2019
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterolChad Moretz, Lindsay Gs Bengtson, Lucie Sharpsten, et al.
Multidisciplinary Respiratory Medicine|October 20, 2018
The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural modelsAmi R Buikema, Lee Brekke, Amy Anderson, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Health Affairs Scholar|January 15, 2026
Decomposition of trauma care prices between 2019 and 2022 in the US commercially insured populationElena Andreyeva, Eleena Koep, Protima Advani, et al.
Current Medical Research and Opinion|August 10, 2018
Cost of subcutaneous immunotherapy in a large insured population in the United StatesJianbin Mao, Kim A Heithoff, Eleena Koep, et al.
Current Medical Research and Opinion|June 18, 2021
Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illnessFelicia Forma, Eleena Koep, John White, et al.
Pragmatic and Observational Research|June 24, 2021
Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart AbstractionCarolyn Martin, Eleena Koep, John White, et al.
Pulmonary Circulation|November 14, 2018
Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US databaseSean Studer, Michael Hull, Janis Pruett, et al.
Health Services Research|August 2, 2023
Role of prices in driving the variation in spending across medical groupsAteev Mehrotra, Emily D Parker, Eleena Koep, et al.
The American Journal of Managed Care|July 27, 2021
Variation in spending associated with primary care practicesSamuel Moy, Eleena Koep, Emily D Parker, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 20, 2019
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort studyChad Moretz, Lucie Sharpsten, Lindsay Gs Bengtson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2019
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterolChad Moretz, Lindsay Gs Bengtson, Lucie Sharpsten, et al.
Multidisciplinary Respiratory Medicine|October 20, 2018
The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural modelsAmi R Buikema, Lee Brekke, Amy Anderson, et al.
Pageof 2